With a market cap of $20.5 billion, Viatris Inc. (VTRS) is a global healthcare company committed to empowering people worldwide to live healthier lives at every stage. With a diverse portfolio spanning generics, established brands, and innovative medicines, it delivers effective, scalable healthcare solutions to address significant unmet needs globally.
Shares of the Canonsburg, Pennsylvania-based company have surpassed the broader market over the past 52 weeks. VTRS stock has soared 96.7% over this time frame, while the broader S&P 500 Index ($SPX) has gained nearly 21%. Moreover, the stock has returned 41.2% on a YTD basis, compared to SPX's 11.9% rise.
